Your browser doesn't support javascript.
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.
Yadav, Pragya D; Nyayanit, Dimpal A; Majumdar, Triparna; Patil, Savita; Kaur, Harmanmeet; Gupta, Nivedita; Shete, Anita M; Pandit, Priyanka; Kumar, Abhinendra; Aggarwal, Neeraj; Narayan, Jitendra; Vijay, Neetu; Kalawat, Usha; Sugunan, Attayur P; Munivenkatappa, Ashok; Sharma, Tara; Devi, Sulochna; Majumdar, Tapan; Jaryal, Subhash; Bakshi, Rupinder; Joshi, Yash; Sahay, Rima; Shastri, Jayanti; Singh, Mini; Kumar, Manoj; Rawat, Vinita; Dutta, Shanta; Yadav, Sarita; Krishnasamy, Kaveri; Raut, Sharmila; Biswas, Debasis; Borkakoty, Biswajyoti; Verma, Santwana; Rani, Sudha; Deval, Hirawati; Patel, Disha; Turuk, Jyotirmayee; Malhotra, Bharti; Fomda, Bashir; Nag, Vijaylakshmi; Jain, Amita; Bhargava, Anudita; Potdar, Varsha; Cherian, Sarah; Abraham, Priya; Gopal, Anjani; Panda, Samiran; Bhargava, Balram.
  • Yadav PD; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Nyayanit DA; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Majumdar T; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Patil S; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Kaur H; Indian Council of Medical Research, New Delhi 110029, India.
  • Gupta N; Indian Council of Medical Research, New Delhi 110029, India.
  • Shete AM; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Pandit P; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Kumar A; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Aggarwal N; Indian Council of Medical Research, New Delhi 110029, India.
  • Narayan J; Indian Council of Medical Research, New Delhi 110029, India.
  • Vijay N; Indian Council of Medical Research, New Delhi 110029, India.
  • Kalawat U; Sri Venkateswara Institute of Medical Sciences, Tirupati 517507, India.
  • Sugunan AP; ICMR-NIV Field Unit, Kerala 688005, India.
  • Munivenkatappa A; ICMR-NIV, Bangalore Unit, Bangalore 560029, India.
  • Sharma T; VRDL Sikkim Government College of Nursing, Gangtok 737101, India.
  • Devi S; Regional Institute of Medical Sciences IMPHAL, Imphal 795004, India.
  • Majumdar T; Government Medical College, Agartala, Tripura 799006, India.
  • Jaryal S; Dr. Rajendra Prasad Government Medical College, (H.P.), Kangra 176001, India.
  • Bakshi R; Government Medical College, Patiala 147001, India.
  • Joshi Y; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Sahay R; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Shastri J; Kasturba Hospital for Infectious Diseases, Mumbai 400034, India.
  • Singh M; Post Graduate Institute of Medical Education & Research, Chandigarh 160012, India.
  • Kumar M; Rajendra Institute of Medical Sciences, Ranchi 834009, India.
  • Rawat V; Government Medical College, Haldwani 263129, India.
  • Dutta S; National Institute of Cholera and Enteric Diseases, Kolkata 700010, India.
  • Yadav S; Bhagat Phool Singh Government Medical College, Sonipat 131305, India.
  • Krishnasamy K; King Institute of Preventive Medicine & Research, Chennai 600032, India.
  • Raut S; Indira Gandhi Government Medical College & Hospital, Nagpur 440018, India.
  • Biswas D; All India Institute of Medical Sciences, Bhopal 462020, India.
  • Borkakoty B; Regional Medical Research Centre, Dibrugarh 786010, India.
  • Verma S; Indira Gandhi Medical College & Hospital, Shimla 171001, India.
  • Rani S; Osmania Medical College, Hyderabad 500095, India.
  • Deval H; Regional Medical Research Center Gorakhpur, Gorakhpur 273013, India.
  • Patel D; B.J. Medical College, Ahmedabad 380016, India.
  • Turuk J; RMRC, Bhubaneswar 751023, India.
  • Malhotra B; Sawai Man Singh Medical College, Jaipur 302004, India.
  • Fomda B; Sher-I-Kashmir Institute of Medical Sciences, Srinagar 190011, India.
  • Nag V; All India Institute of Medical Sciences, Jodhpur 342005, India.
  • Jain A; Department of Microbiology, King George's Medical University, Lucknow 226003, India.
  • Bhargava A; All India Institute of Medical Sciences, Raipur, Raipur 492099, India.
  • Potdar V; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Cherian S; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Abraham P; Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune 411021, India.
  • Gopal A; Indian Institute of Science Education and Research, Pune 411008, India.
  • Panda S; Indian Council of Medical Research, New Delhi 110029, India.
  • Bhargava B; Indian Council of Medical Research, New Delhi 110029, India.
Viruses ; 13(5)2021 05 17.
Article in English | MEDLINE | ID: covidwho-1234829
ABSTRACT
The number of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) cases is increasing in India. This study looks upon the geographic distribution of the virus clades and variants circulating in different parts of India between January and August 2020. The NPS/OPS from representative positive cases from different states and union territories in India were collected every month through the VRDLs in the country and analyzed using next-generation sequencing. Epidemiological analysis of the 689 SARS-CoV-2 clinical samples revealed GH and GR to be the predominant clades circulating in different states in India. The northern part of India largely reported the 'GH' clade, whereas the southern part reported the 'GR', with a few exceptions. These sequences also revealed the presence of single independent mutations-E484Q and N440K-from Maharashtra (first observed in March 2020) and Southern Indian States (first observed in May 2020), respectively. Furthermore, this study indicates that the SARS-CoV-2 variant (VOC, VUI, variant of high consequence and double mutant) was not observed during the early phase of virus transmission (January-August). This increased number of variations observed within a short timeframe across the globe suggests virus evolution, which can be a step towards enhanced host adaptation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Phylogeography / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Year: 2021 Document Type: Article Affiliation country: V13050925

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Phylogeography / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Year: 2021 Document Type: Article Affiliation country: V13050925